N-Acetylcysteine inhibits platelet–monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial

N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with Type 2 diabetes mellitus

(2014) A. Masha et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

High-Dose N-Acetylcysteine Therapy for Novel H1N1 Influenza Pneumonia

(2013) Kang Yiu Lai   ANNALS OF INTERNAL MEDICINE

Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes

(2011) Kyle R Gibson et al.   Cardiovascular Diabetology

Acetylcysteine as Adjuvant Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Antibody

(2011) F. J. FERNANDEZ-FERNANDEZ et al.   JOURNAL OF RHEUMATOLOGY

Microparticles: targets and tools in cardiovascular disease

(2011) Maria Carmen Martinez et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Cell-Derived Microparticles in the Pathogenesis of Cardiovascular Disease

(2010) Maarten E. Tushuizen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis

(2010) E. SHANTSILA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Microparticles: Key Protagonists in Cardiovascular Disorders

(2010) Nicolas Amabile et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Evaluation of the Antioxidant Properties of N-acetylcysteine in Human Platelets: Prerequisite for Bioconversion to Glutathione for Antioxidant and Antiplatelet Activity

(2009) Kyle R Gibson et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Endothelial Dysfunction: From Molecular Mechanisms to Measurement, Clinical Implications, and Therapeutic Opportunities

(2008) Michelle Le Brocq et al.   ANTIOXIDANTS & REDOX SIGNALING

Monocyte Functional Responsiveness After PSGL-1–Mediated Platelet Adhesion Is Dependent on Platelet Activation Status

(2008) Stylianos Bournazos et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Long-Term N-Acetylcysteine and L-Arginine Administration Reduces Endothelial Activation and Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes

(2008) V. Martina et al.   DIABETES CARE

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial

(2008) Hisao Ogawa   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION